HealthcareClinical Documentation4HighICU Nurse$ implied

ICU nurses are uncertain whether Epic MAR and Alaris pump integration will restrict their ability to manually override pump settings for critical tasks like pressor titration and sedation boluses, potentially compromising patient safety during rapid clinical changes.

Existing integration may enforce rigid order parameters from Epic into the pump, preventing nurses from making real-time, clinically necessary adjustments such as increasing pressor rates faster than ordered or bolusing sedation more frequently, which are common in ICU care.

47
0
Opp. Score
47
Severity
4High
Willingness to Pay
implied
Added
Jul 15, 2026

Implied Software Gaps

  • A configurable safety middleware that permits manual pump overrides while documenting clinical justification and seeking retrospective provider approval
App Concept

FlexiGuard ICU Infusion Bridge

A middleware platform that sits between Epic MAR and Alaris pumps, enabling real-time override and audit of infusion parameters with contextual clinical documentation. It ensures patient safety by allowing nurse-driven deviations from order parameters when clinically indicated, while capturing rationale and automating provider notification for co-signature.

Key Features
  • Real-time override interface for pump settings outside order parameters with forced reason documentation
  • Automated alert to provider for co-signature when nurse overrides order limits
  • Two-way sync that updates Epic MAR with actual infused rates and boluses
  • Customizable guardrails per medication and unit (e.g., ICU vs. acute care)
Target Users: ICU nurses and intensivists in hospitals using Epic and Alaris infusion pumps
Revenue Model: $50 per bed per month SaaS subscription, with tiered pricing for enterprise hospital systems

Existing Solutions Mentioned

Epic MARAlaris infusion pump

Want to go deeper?

Sign up to save ideas, run AI analysis, and track opportunities in your personal workspace. Founding members get full access.

Join Beta

Solutions (0)

Discussion (0)

No comments yet

Join the beta — full access for the first 1,000 builders

Join Beta